BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

410 related articles for article (PubMed ID: 16740794)

  • 1. The cancer and leukemia group B pharmacology and experimental therapeutics committee: a historical perspective.
    Ratain MJ; Miller AA; McLeod HL; Venook AP; Egorin MJ; Schilsky RL
    Clin Cancer Res; 2006 Jun; 12(11 Pt 2):3612s-6s. PubMed ID: 16740794
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The cancer and leukemia group B oncology nursing committee (1983-2006): a history of passion, commitment, challenge, and accomplishment.
    Smith EL; Skosey C; Armer J; Berg D; Cirrincione C; Henggeler M
    Clin Cancer Res; 2006 Jun; 12(11 Pt 2):3638s-41s. PubMed ID: 16740799
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cancer and leukemia group B gastrointestinal cancer committee.
    Goldberg RM; Niedzwiecki D; Bertagnolli M; Blackstock AW; Tepper JE; Mayer RJ
    Clin Cancer Res; 2006 Jun; 12(11 Pt 2):3589s-95s. PubMed ID: 16740790
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The cancer and leukemia group B cancer in the elderly committee: addressing a major cancer need.
    Cohen HJ; Muss HB
    Clin Cancer Res; 2006 Jun; 12(11 Pt 2):3606s-11s. PubMed ID: 16740793
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lessons learned from independent central review.
    Ford R; Schwartz L; Dancey J; Dodd LE; Eisenhauer EA; Gwyther S; Rubinstein L; Sargent D; Shankar L; Therasse P; Verweij J
    Eur J Cancer; 2009 Jan; 45(2):268-74. PubMed ID: 19101138
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fifty years of clinical research by the leukemia committee of the cancer and leukemia group B.
    Larson RA; Stone RM; Mayer RJ; Schiffer CA
    Clin Cancer Res; 2006 Jun; 12(11 Pt 2):3556s-63s. PubMed ID: 16740785
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cancer and leukemia group B breast committee: decades of progress and plans for the future.
    Hudis CA; Winer EP
    Clin Cancer Res; 2006 Jun; 12(11 Pt 2):3576s-80s. PubMed ID: 16740788
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The cancer and leukemia group B pathology committee at 50.
    Compton C
    Clin Cancer Res; 2006 Jun; 12(11 Pt 2):3617s-21s. PubMed ID: 16740795
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Processes to activate phase III clinical trials in a Cooperative Oncology Group: the Case of Cancer and Leukemia Group B.
    Dilts DM; Sandler AB; Baker M; Cheng SK; George SL; Karas KS; McGuire S; Menon GS; Reusch J; Sawyer D; Scoggins M; Wu A; Zhou K; Schilsky RL;
    J Clin Oncol; 2006 Oct; 24(28):4553-7. PubMed ID: 17008694
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A concise history of the cancer and leukemia group B.
    Schilsky RL; McIntyre OR; Holland JF; Frei E
    Clin Cancer Res; 2006 Jun; 12(11 Pt 2):3553s-5s. PubMed ID: 16740784
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cancer and leukemia group B surgery committee.
    Kohman LJ
    Clin Cancer Res; 2006 Jun; 12(11 Pt 2):3622s-7s. PubMed ID: 16740796
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activities and accomplishments of the cancer and leukemia group B genitourinary committee.
    Small EJ; Halabi S; Kantoff P; D'Amico A; Stadler W; Kelley WK; Mohler J; Bajorin D; Vogelzang NJ
    Clin Cancer Res; 2006 Jun; 12(11 Pt 2):3596s-600s. PubMed ID: 16740791
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The cancer and leukemia group B respiratory committee.
    Vokes EE; Perry MC; Kindler HL; Green MR
    Clin Cancer Res; 2006 Jun; 12(11 Pt 2):3581s-8s. PubMed ID: 16740789
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radiation oncology research in the cancer and leukemia group B.
    Bogart JA; Seagren SL; Glicksman A
    Clin Cancer Res; 2006 Jun; 12(11 Pt 2):3628s-34s. PubMed ID: 16740797
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The cancer and leukemia group B lymphoma committee.
    Cheson BD; Canellos GP
    Clin Cancer Res; 2006 Jun; 12(11 Pt 2):3572s-5s. PubMed ID: 16740787
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An overview of the optimal planning, design, and conduct of phase I studies of new therapeutics.
    LoRusso PM; Boerner SA; Seymour L
    Clin Cancer Res; 2010 Mar; 16(6):1710-8. PubMed ID: 20215546
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phase II clinical trial design: methods in translational research from the Genitourinary Committee at the Eastern Cooperative Oncology Group.
    Gray R; Manola J; Saxman S; Wright J; Dutcher J; Atkins M; Carducci M; See W; Sweeney C; Liu G; Stein M; Dreicer R; Wilding G; DiPaola RS
    Clin Cancer Res; 2006 Apr; 12(7 Pt 1):1966-9. PubMed ID: 16609005
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Controlled randomized clinical trials].
    Jaillon P
    Bull Acad Natl Med; 2007; 191(4-5):739-56; discussion 756-8. PubMed ID: 18225427
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The cancer and leukemia group B transplant committee.
    Linker C; Hurd D
    Clin Cancer Res; 2006 Jun; 12(11 Pt 2):3635s-7s. PubMed ID: 16740798
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.